UK researchers have found greater exposure to particulate air pollution was associated with self-reported age-related macular degeneration (AMD), while particulate matter, nitrogen dioxide (NO2) and
An international team of researchers, led by the University of Leicester, UK, have identified the spectrum of genetic changes responsible for foveal hypoplasia and when they cause problems in
Against a backdrop of potential Medicare funding cuts for anti-vascular endothelial growth factor (anti-VEGF) injections, Optometry Australia (OA) has urged the nation’s major political parties to commit to investing AU$1 million over two years in a collaborative-care pilot study to more effectively
Ophthalmic Instrument Company (OIC) is set to introduce the newly launched DORC EVA Nexus phaco-vitrectomy system to New Zealand. With a roadshow planned as soon as the first EVA Nexus hits our shores, there was significant interest in the new technology at the RANZCO NZ meeting, said OIC’s Tim Way.
Promising bigger and better things, the thrice-moved RANZCO in-person conference in Brisbane is now firmly fixed for Saturday 27 October to Tuesday 1 November 2022 for the 53rd Congress with preparations well underway.
Now available for sale in New Zealand, LKC Technologies’ RETeval visual electrodiagnostic system is a portable, handheld, functional diagnostic device for medical professionals to diagnose patients with diabetic retinopathy, glaucoma, central retinal vein occlusion, paediatric nystagmus and inherite
US researchers have found that activating a receptor known to protect cells from stress could be key to the survival of neurons impacted by glaucoma.
Reflecting two of the main themes of the RANZCO NZ conference, portable, space-saving devices for use with more remote communities, and more environmentally friendly technologies, were the main focus on Device Technologies’ stand.
Aside from a GST increase in 2010, the Ministry of Health’s (MoH) contact lens (CL) subsidy hasn’t been revised since its inception in 1988 and is now outdated and falling short of the cost of caring for patients, according to several industry professionals.
In December 2021, we described normal variations in the iris and iris changes in certain genetic conditions, systemic diseases, and malignant tumours. In the second part of this mini-series, we explore eye conditions resulting in iris transillumination defects and rubeosis.
A large-scale US study has found the incidence of retinal vein occlusions (RVO) increases in the six months following Covid-19 infection.
Covid-19 has impacted the eyecare of more than one in four (26%) Australian children, with those in remote areas being hardest hit (32% vs 22%), according to the latest Little Aussie Eyes Report.